NSEAnalysts/Institutional Investor Meet/Con. Call Updates11 Sept 2026 · 11 Sept 2026, 04:46 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Supriya Lifescience Limited · SUPRIYA
✦ AI Summary
Supriya Lifescience Limited has informed the Exchange about a schedule of meet with Analyst/Institutional Investors on September 17, 2026, and has uploaded the Investor Presentation on the Stock Exchanges and its website.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Supriya Lifescience Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
SUPRIYA_11092026164118_IntimationofMeeting110926.pdf
View document text
September 11, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block,
Dalal Street, Bandra-Kurla Complex
Mumbai- 400 001 Bandra (E), Mumbai - 400 051
Scrip Code: 543434 NSE Symbol: SUPRIYA
Dear Sir/Madam,
Subject: Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing
Obligations and Disclosure Requirements), Regulations 2015
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the
officials of our Company, Supriya Lifescience Limited (“Company”) will be interacting with
Analyst/Institutional Investors as per details below:
Sr. Meeting with Date & Time Format Mode
1. Investors Group Meeting Thursday, September 17, 2026 Group Meeting Virtual
11:00 AM – 12:00 NOON.
This is to further inform you that the copy of the Investor Presentation has been uploaded on the Stock
Exchanges and on the Company’s website www.supriyalifescience.com for your information and for the
information of your members and the public at large.
This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
Note: The above date is subject to change. Change may happen due to exigencies on the part of the
Company or Analyst/Investor/Fund.
Request you to kindly take the same on record.
Thanking you,
For Supriya Lifescience Limited
Prachi Sathe
Company Secretary & Compliance Officer
Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India.
Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX
CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India.
Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com
GOVT. RECOGNISED EXPORT HOUSE